Embracing Monogenic Parkinson’s Disease: The MJFF Global Genetic PD Cohort

Embracing Monogenic Parkinson’s Disease: The MJFF Global Genetic PD Cohort
Mov Disord. 2023 Jan 24. doi: 10.1002/mds.29288. Online ahead of print.ABSTRACTBACKGROUND: As gene-targeted therapies are increasingly being developed for Parkinson's disease (PD), identifying and characterizing carriers of specific genetic pathogenic variants is imperative. Only a small fraction of the estimated number of subjects with monogenic PD worldwide are currently represented in the literature and availability of clinical data and clinical ... read more
Source: PubMedPublished on 2023-01-24By Eva-Juliane Vollstedt